Usage of disease specific tube feed will improve glucose control in diabetic patients.
ID
Bron
Verkorte titel
Aandoening
Type 2 diabetic patients that are not capable of eating and/or drinking sufficiently and are in need of nutritional support with tube feeding to meet their energy requirements.
Ondersteuning
P.O. Box 7005
6700 CA Wageningen, The Netherlands
P.O. Box 7005
6700 CA Wageningen, The Netherlands
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Postprandial glucose response.
Achtergrond van het onderzoek
In this trial disease specific tube feed will be compared with a standard tube feed on glucose control in diabetic patients.
Doel van het onderzoek
Usage of disease specific tube feed will improve glucose control in diabetic patients.
Onderzoeksopzet
N/A
Onderzoeksproduct en/of interventie
Duration intervention: 12 weeks.
Intervention group: disease specific tube feed;
Control group: isocaloric standard tube feed.
Publiek
P.O. Box 7005
Tessa Rossenberg, van
Wageningen 6700 CA
The Netherlands
+31 (0)317 467805
tessa.vanrossenberg@numico-research.nl
Wetenschappelijk
P.O. Box 7005
Tessa Rossenberg, van
Wageningen 6700 CA
The Netherlands
+31 (0)317 467805
tessa.vanrossenberg@numico-research.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Diagnosis type 2 diabetes;
2. Age > 18;
3. HbA1c between 6.5%-8.5%;
4. In need for nutritional support by tube feeding for at least 12 weeks;
5. Functioning GI tract, eligible for tube feeding;
6. Nutrition via PEG or nasogastric tube;
7. Having given written informed consent.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Pregnant or lactating women or women planning to become pregnant;
2. Usage of a disease specific tube feed within past 4 weeks;
3. Acute severe heart failure, end stage ver failure or renal failure requiring dialysis;
4. Any acute gastrointestinal disease within past 2 weeks;
5. Concomitant therapy with glucocorticoids or acarbose;
6. Nutrition via PEJ;
7. Drug or alcohol abuse;
8. Participation in other trials within four weeks of study entry.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL540 |
NTR-old | NTR584 |
Ander register | : 100088 |
ISRCTN | ISRCTN57864852 |